Suzhou Genhouse Bio Co., Ltd.
Clinical trials sponsored by Suzhou Genhouse Bio Co., Ltd., explained in plain language.
-
New pill combo aims to block Cancer's fuel supply
Disease control Not yet recruitingThis study tests two experimental pills (GH55 and GH21) taken together to treat advanced solid tumors that have certain genetic changes (MAPK pathway). The goal is to see if the combination is safe, tolerable, and shrinks tumors. About 152 adults whose cancer has not responded to…
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Genhouse Bio Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 11:50 UTC
-
New drug duo targets tough cancers in phase 2 trial
Disease control Not yet recruitingThis study tests a combination of two experimental drugs (GH21 and D-1553) in people with advanced solid tumors that have a specific genetic change called KRASG12C. The trial includes two groups: one for non-small cell lung cancer and another for other solid tumors, all in patien…
Phase: PHASE2 • Sponsor: Suzhou Genhouse Bio Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 11:08 UTC